Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
2
×
clinical trials
europe blog main
2
×
fda
2
×
life sciences
national
national blog main
abaloparatide
abbvie
allergan
biohaven
cgpr
eli lilly
europe top stories
european commission
merck
migraine
national top stories
new york blog main
osteoporosis
radius health
romosozumab
san francisco blog main
san francisco top stories
teriparatide
ucb
What
nod
2
×
wins
adults
allergan
amgen
amgen’s
approval
approved
carries
class
developed
drug
europe
european
fda
heart
marketing
medicine
medicines
migraine
monday
new
osteoporosis
pill
raise
risk
treat
treatment
ubrelvy
ubrogepant
warning
Language
unset
Current search:
fda
×
biotech
×
" europe blog main "
×
nod
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning